Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Zephyrhills, Florida on April 16, 2022. This dispensary aims to enhance patient access and features grand opening specials, including a 25% discount for registered patients. Trulieve is the leading medical cannabis provider in Florida, offering a wide range of THC and CBD products. The company emphasizes personalized patient care and support through trained retail employees. For more details on Trulieve's operations and other locations, visit trulieve.com.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Fort Myers, Florida, on April 13, 2022. The dispensary, located at 15620 Summerlin Rd, will feature grand opening festivities, including giveaways, food trucks, and a 25% discount for registered patients. As a leading medical cannabis provider, Trulieve offers a diverse range of THC and CBD products in Florida, with a focus on personalized patient care through trained staff. The company aims to build community relationships while expanding access to medical cannabis.
Trulieve Cannabis Corp. has opened its third dispensary in Framingham, Massachusetts on April 3, 2022. This new, 5,000 square foot location aims to provide an elevated in-store experience with a contemporary design. Initially serving adult-use customers, the dispensary will also cater to medical cannabis patients later this Spring. A grand opening celebration is set for April 9, 2022, featuring celebrity appearances and promotional offers. Trulieve continues to expand its footprint in Massachusetts, enhancing customer access to a variety of cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has announced its participation in multiple conferences in April 2022, highlighting strategic engagement with investors. CEO Kim Rivers will lead discussions at the BTIG Global Cannabis Conference on April 6, the Cantor Virtual Cannabis Conference on April 14, and the Benzinga Cannabis Capital Conference on April 20, along with a speech at The Green Market Report's Women's Summit on April 28. Trulieve operates in 11 states, focusing on growth in retail and distribution, particularly in Arizona, Florida, and Pennsylvania.
Trulieve Cannabis Corp. announces an exclusive partnership with DeLisioso LLC to produce and sell the Flamingo Kush pre-rolls in Florida, starting April 15, 2022. DeLisioso, founded by Richard DeLisi, focuses on high-end cannabis products and aims to support families affected by the War on Drugs. The partnership allows Trulieve to expand its product offerings as the leading cannabis provider in Florida. Flamingo Kush, an indica-dominant strain, will be available in all Trulieve dispensaries, showcasing DeLisioso's commitment to quality and social impact.
Trulieve Cannabis Corp. announced the launch of adult-use sales at its Harvest dispensary in Napa, California, starting April 1, 2022. This location is among the first to offer adult-use cannabis following the City Council's approval of a new ordinance on February 1. Harvest of Napa, recognized as the "Best Dispensary" three times by Bohemian Magazine, offers over 90 strains of flower. The company is expanding its retail footprint in California, emphasizing tailored experiences for local communities.
Trulieve Cannabis Corp. announced a record revenue of $938.4 million for 2021, representing an 80% increase year-over-year. The quarterly revenue for Q4 2021 reached $305.3 million, up 36% sequentially. Despite the strong revenue growth, the company experienced a decline in gross margin to 60.3% from 74.1% in 2020, primarily due to diversification into lower-margin markets. Net income for 2021 was $18.0 million, with an adjusted EBITDA of $384.6 million. Trulieve anticipates revenue between $1.3 billion to $1.4 billion for 2022.
Trulieve Cannabis Corp. has opened a new medical cannabis dispensary in Boca Raton, Florida, as of March 16, 2022. The dispensary aims to enhance patient access to medical cannabis, featuring a 25% discount for registered patients during the grand opening. The location provides a wide array of THC and CBD products, and offers services like home delivery and online ordering. Trulieve continues to expand its market presence across Florida, Arizona, and Pennsylvania, focusing on enriching patient care and community engagement.
Trulieve Cannabis Corp. has announced an exclusive partnership with Ethan Zohn, winner of Survivor: Africa and a two-time cancer survivor, to serve as the brand ambassador for Momenta, Trulieve's wellness cannabis brand. Zohn will engage in educational outreach and share his cannabis wellness journey. The partnership aims to enhance cannabis awareness and education across the U.S. Momenta is currently available in Florida, Massachusetts, and West Virginia, offering a range of easy-to-dose products designed to promote overall well-being.
Trulieve Cannabis Corp. will hold a conference call on March 30, 2022 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2021 financial results. The call will feature CEO Kim Rivers, CFO Alex D'Amico, and President Steve White, highlighting the company's recent acquisition of Harvest Health & Recreation. Interested parties can join via phone or through a live audio webcast, with details available in the press release. Trulieve operates across 11 states, focusing on expanding its market presence and customer access.